The U.S. dietary supplements market size was estimated at around USD 50,909.85 million in 2022 and it is projected to hit around USD 88,875.93 million by 2032, growing at a CAGR of 5.73% from 2023 to 2032.
Key Pointers
Report Scope of the U.S. Dietary Supplements Market
Report Coverage | Details |
Market Size in 2022 | USD 50,909.85 million |
Revenue Forecast by 2032 | USD 88,875.93 million |
Growth rate from 2023 to 2032 | CAGR of 5.73% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Companies Covered | Amway; Abbott; Bayer AG; Glanbia plc.; Pfizer Inc.; Archer Daniels Midland; GlaxoSmithKline plc.; NU SKIN; Herbalife Nutrition; Nature's Sunshine Products Inc.; DuPont de Nemours Inc.; NOW Foods |
The demand is anticipated to be driven by the several factors including the aging population, increasing awareness about preventive healthcare, and rising demand for the sports nutrition supplements.
Furthermore, the trend towards self-directed care is also driving demand for the dietary supplements in the U.S. Consumers, those are becoming more proactive in managing their health and are turning to supplements as a way to enhancement their diets and maintain optimal health. As consumers take more responsibility for their health, they are seeking out natural and alternative remedies to improve their health and wellness.
Nutraceutical supplements have received immense popularity and focus in the recent past owing to their nutritional and medicinal benefits, along with being safe for consumption without any significant side effects. Nutraceuticals are also quickly replacing pharmaceuticals in the management and prevention of chronic and acute health problems. These products have ample scope as therapeutic agents with curative and preventive properties. They are generally available over the counter, without requiring a prescription, making them easily accessible to the general public.
The rising health concerns have driven consumers to eat better and lead healthier lives. However, with busy schedules and little time to make healthy, nutritious meals, consumers are relying on dietary supplements to make up for the inadequate intake of the required nutrients. Apart from this, the growing trend of personalized nutrition and the increased spending power of the consumers are expected to have a positive impact on product demand. There is a rising willingness among consumers in the U.S. to pay a premium price for products with better nutritional value. Add to this the growing tendency of companies to use eye-catching packaging and natural ingredients to attract more consumers. This will continue to drive the product adoption in the country.
Nanoencapsulation and microencapsulation technologies have gained popularity during the past few years owing to the controlled release and minimum utilization of the ingredients. The introduction and application of encapsulation technologies in the fortification of food & beverage products offer sports nutrition ingredients immense scope for the growth. Furthermore, ascending demand for the naturally derived ingredients in light of increasing health concerns related to synthetic ingredients is expected to fuel the penetration of herbal supplements in the sports nutrition industry.
Mounting health concerns stemming from hectic work schedules and unhealthy eating habits have increased consumer focus on health and fitness. Rising cases of obesity in the country have also driven people to exercise more. This rising participation of consumers in various physical activities, coupled with increasing international and national sporting events, has propelled demand for the sports nutritional supplements.
Ingredient Insights
Based on ingredient, the market is segmented into vitamins, botanicals, minerals, proteins & amino acids, fibers & specialty carbohydrates, omega fatty acids, probiotics, and others. In 2022, vitamins held a dominant position in the market; accounting for a share of 30.14%. This is primarily attributed to changing preferences and progressive aging of the U.S. population.
Americans are becoming increasingly health conscious and are interested in maintaining a healthy diet and lifestyle. Vitamins are among the most commonly consumed dietary supplements, especially those who may not get all the nutrients they need from their diet alone. Vitamins can be formulated with specific nutrients and doses to address various health concerns, such as immunity, bone health, and brain function. Vitamins A, B, C, and D-are expected to gain popularity among working professionals and sportspersons during the forecast period.
Probiotics and omega fatty acids are also expected to record a significant growth rate of 6.76% and 6.63% respectively during the forecast period. The demand for probiotic supplements stems from increasing gut-related issues and food sensitivities. Probiotic supplements are further beneficial for immunity and preventive healthcare which is likely to drive its growth during the forecast period.
Form Insights
Based on form, the market is segmented into tablets, capsules, soft gels, powders, gummies, liquid, and others. The capsules segment dominated the market with a revenue share of 30.34% in 2022 and is expected to retain its dominance during the forecast period.
The demand for capsules is attributed to its convenience and design. Capsules provide protection to the active ingredients from light, moisture, and oxygen. This further helps to preserve the potency and quality of the supplement during time leading to increased shelf-life. The rising importance of microencapsulation in the health & wellness industry to ensure the controlled release of finished products, along with maintaining the color characteristics, is expected to encourage manufacturers to opt for capsule dosage forms throughout the forecast period.
Gummies are expected to record the fastest CAGR of 6.73% during the forecast period. Over the recent past, manufacturers have focused on launching gummy supplements owing to its increasing preference among consumers. Gummies are likely to emerge as a profitable category during the forecast period. These were initially formulated for adults unwilling to take pills and later became popular among other groups as well because of their visual appeal and easy digestion. According to a survey by The Harris Poll found that 28.0% of adults in the U.S. have tried gummy vitamins in the past year, and 53.0% of those who tried them reported taking them daily. These trends indicate the increasing consumer preference towards gummy supplements in the U.S.
Application Insights
In 2022, the general health segment dominated the market with a revenue share of 23.69% owing to the growing emphasis on general and overall health and wellness. According to a survey conducted by the Council for Responsible Nutrition (CRN) in 2021, found that 80.0% of Americans were incorporating dietary supplements into their routines, indicating a 7.0% rise from the preceding year. The main driving force behind this trend is changing consumer dietary habits concerning preventive healthcare.
Cardiac health is projected to record the fastest CAGR of 6.571% during the forecast period. The rising occurrences of cardiovascular diseases owing to sedentary lifestyles, especially among those in the age group of 30 to 40 years, and fluctuating dietary patterns are expected to propel the intake of supplements featuring ingredients such as omega-3 fatty acids, coenzyme Q10, and magnesium to regulate heart health.
End-user Insights
In terms of revenue, the adults dominated the market with a revenue share of 46.25% in 2022 owing to growing health awareness among working professionals and athletes about the importance of maintaining a balanced diet which creates a significant demand for the dietary supplements to maintain general health.
The U.S. consumers especially women are incorporating dietary supplements in their established health and wellness routines due to the increasing health consciousness. Furthermore, sports athletes are likely to influence the demand for protein-based supplements used for muscle growth, energy & weight management, and recovery. Additionally, sedentary lifestyle is very common in the U.S. and it is largely associated with a range of health issues, including obesity, cardiovascular disease, and metabolic disorders. This is expected to drive demand for the dietary supplements among adults to mitigate the health-related risks.
Type Insights
In terms of revenue, the OTC (Over-the-Counter) segment dominated the market with a revenue share of 85.19% in 2022. The consumer trend of self-directed health care is likely to drive demand for the OTC supplements. OTC supplements are often less expensive than prescription supplements, which can make them an affordable option for the consumers. With the growth of e-commerce and online retailers, it has become easier for the consumers to purchase dietary supplements online, which has contributed to the segment growth.
Consumers are opting for OTC supplements owing to the factors such as illness prevention and treatment. Consumers are shifting towards natural over-the-counter products due to their increased efficacy in treatments and health management. The OTC segment is anticipated to develop at a significant CAGR of 5.76% during the forecast period.
Distribution Channel Insights
The offline distribution channel is estimated to dominate the market with a revenue share of 78.16% in 2022. An increase in prescribed dietary supplements by the medical practitioners for treating gastrointestinal disorders, immunity-related issues, bone health, folic acid deficiencies, heart health, and age-related macular degeneration, among others, is a key factor driving demand for the dietary supplements through offline distribution channels.
Apart from this, geriatric consumers in the U.S. prefer purchasing dietary supplements through traditional distribution channels as they are not tech-savvy. This further boosts the segment growth.
The online distribution channel is expected to record the fastest growth rate of 6.33% during the forecast period. The advent of COVID-19 outbreak has accelerated the growth of e-commerce in general, including the online sales of dietary supplements. According to a 2021 survey by Nutrition Business Journal online sales of dietary supplements in the U.S. increased by 20.8% to USD 14.3 billion in 2020, representing a significant growth trend.
Bulk discounts, convenience of online shopping, and 24/7 availability of wide range of products is likely to favor the growth of online distribution channels in the U.S. dietary supplements market.
U.S. Dietary Supplements Market Segmentations:
By Ingredient
By Form
By Application
By End-user
By Type
By Distribution Channel
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Distribution Channel Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Dietary Supplements Market
5.1. COVID-19 Landscape: U.S. Dietary Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Dietary Supplements Market, By Ingredient
8.1. U.S. Dietary Supplements Market, by Ingredient, 2023-2032
8.1.1. Vitamins
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Botanicals
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Minerals
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Proteins & Amino acids
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Fibers & Specialty Carbohydrates
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Omega Fatty Acids
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Probiotics
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Dietary Supplements Market, By Form
9.1. U.S. Dietary Supplements Market, by Form, 2023-2032
9.1.1. Tablets
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Capsules
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Soft Gels
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Powders
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Gummies
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Liquids
9.1.6.1. Market Revenue and Forecast (2020-2032)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Dietary Supplements Market, By Energy & Weight Management
10.1. U.S. Dietary Supplements Market, by Application, 2023-2032
10.1.1. Energy & Weight Management
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. General Health
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Bone & Joint Health
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Gastrointestinal Health
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Immunity
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Cardiac Health
10.1.6.1. Market Revenue and Forecast (2020-2032)
10.1.7. Anti-cancer
10.1.7.1. Market Revenue and Forecast (2020-2032)
10.1.8. Diabetes
10.1.8.1. Market Revenue and Forecast (2020-2032)
10.1.9. Lungs Detox/Cleanse
10.1.9.1. Market Revenue and Forecast (2020-2032)
10.1.10. Skin/Hair/Nails
10.1.10.1. Market Revenue and Forecast (2020-2032)
10.1.11. Sexual Health
10.1.11.1. Market Revenue and Forecast (2020-2032)
10.1.12. Brain/Mental Health
10.1.12.1. Market Revenue and Forecast (2020-2032)
10.1.13. Insomnia
10.1.13.1. Market Revenue and Forecast (2020-2032)
10.1.14. Menopause
10.1.14.1. Market Revenue and Forecast (2020-2032)
10.1.15. Anti-aging
10.1.15.1. Market Revenue and Forecast (2020-2032)
10.1.16. Prenatal Health
10.1.16.1. Market Revenue and Forecast (2020-2032)
10.1.17. Others
10.1.17.1. Market Revenue and Forecast (2020-2032)
Chapter 11. U.S. Dietary Supplements Market, By End-user
11.1. U.S. Dietary Supplements Market, by End-user, 2023-2032
11.1.1. Adults
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Geriatric
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Pregnant Women
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Children
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Infants
11.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 12. U.S. Dietary Supplements Market, By Type
12.1. U.S. Dietary Supplements Market, by Type, 2023-2032
12.1.1. OTC
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Prescribed
12.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 13. U.S. Dietary Supplements Market, By Distribution Channel
13.1. U.S. Dietary Supplements Market, by Distribution Channel, 2023-2032
13.1.1. Offline
13.1.1.1. Market Revenue and Forecast (2020-2032)
13.1.2. Online
13.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 14. U.S. Dietary Supplements Market, Regional Estimates and Trend Forecast
14.1. U.S.
14.1.1. Market Revenue and Forecast, by Ingredient (2020-2032)
14.1.2. Market Revenue and Forecast, by Form (2020-2032)
14.1.3. Market Revenue and Forecast, by Application (2020-2032)
14.1.4. Market Revenue and Forecast, by End-user (2020-2032)
14.1.5. Market Revenue and Forecast, by Type (2020-2032)
14.1.6. Market Revenue and Forecast, by Distribution Channel (2020-2032)
Chapter 15. Company Profiles
15.1. Amway
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Abbott
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Bayer AG
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Glanbia plc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Pfizer Inc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Archer Daniels Midland
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. GlaxoSmithKline plc.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. NU SKIN
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Herbalife Nutrition
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Nature's Sunshine Products Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms